Literature DB >> 24762580

MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.

Yang Li1, Qiming Huang1, Xuehui Shi1, Xiang Jin1, Li Shen2, Xiaolin Xu1, Wenbin Wei3.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) contribute to tumorigenesis by acting as either oncogenes or tumor suppressor genes. In this study, we investigated the role of miR-145 in the pathogenesis of uveal melanoma.
METHODS: Expression profiles of miRNAs in uveal melanoma were performed using Agilent miRNA array. Quantitative real-time polymerase chain reaction was used to screen the expression levels of miR-145 in normal uveal tissue, uveal melanoma tissue, and uveal melanoma cell lines. Lenti-virus expression system was used to construct MUM-2B and OCM-1 cell lines with stable overexpression of miR-145. Cell proliferation, cell cycle, and cell apoptosis of these miR-145 overexpression cell lines were examined by MTT assay and flow cytometry respectively. The target genes of miR-145 were predicted by bioinformatics and confirmed using a luciferase reporter assay. The expression of insulin-like growth factor-1 receptor (IGF-1R), insulin receptor substrate-1 (IRS-1) proteins was determined by Western blotting analysis. IRS-1 was knocked down in OCM-1 cells. TUNEL, BrdU, and flow cytometry assay were performed in IRS-1 knocked down OCM-1 cell lines to analyze its function.
RESULTS: Forty-seven miRNAs were up regulated in uveal melanoma and 61 were down regulated. miR-145 expression was significantly lower in uveal melanoma sample and the cell lines were compared with normal uveal sample. Overexpression of miR-145 suppressed cell proliferation by blocking the G1 phase entering S phase in uveal melanoma cells, and promoted uveal melanoma cell apoptosis. IRS-1 was identified as a potential target of miR-145 by dual luciferase reporter assay. Knocking down of IRS-1 had similar effect as overexpression of miR-145.
CONCLUSION: miR-145 might act as a tumor suppressor in uveal melanoma, and downregulation of the target IRS-1 might be a potential mechanism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762580

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

1.  Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.

Authors:  Chen Li; Na Xu; Yu-Qiang Li; Yu Wang; Zhi-Tu Zhu
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 2.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 3.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

4.  Current molecular and clinical insights into uveal melanoma (Review).

Authors:  Matteo Fallico; Giuseppina Raciti; Antonio Longo; Michele Reibaldi; Vincenza Bonfiglio; Andrea Russo; Rosario Caltabiano; Giuseppe Gattuso; Luca Falzone; Teresio Avitabile
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

5.  Novel circular RNA expression profile of uveal melanoma revealed by microarray.

Authors:  Xuan Yang; Yang Li; Yueming Liu; Xiaolin Xu; Yingzhi Wang; Yanni Yan; Wenjia Zhou; Jingyan Yang; Wenbin Wei
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

6.  Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways.

Authors:  Sha Liu; Guozhen Gao; Dexiong Yan; Xiangjun Chen; Xingwei Yao; Shuzhong Guo; Guirong Li; Yu Zhao
Journal:  Cancer Med       Date:  2017-03-23       Impact factor: 4.711

Review 7.  MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators.

Authors:  Karen Aughton; Helen Kalirai; Sarah E Coupland
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 8.  Update on uveal melanoma: Translational research from biology to clinical practice (Review).

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Natalio García-Honduvilla; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Miguel A Teus
Journal:  Int J Oncol       Date:  2020-10-22       Impact factor: 5.650

9.  Bergamottin Induces DNA Damage and Inhibits Malignant Progression in Melanoma by Modulating miR-145/Cyclin D1 Axis.

Authors:  Zhongfang Zhao; Nong Liao
Journal:  Onco Targets Ther       Date:  2021-06-17       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.